We further show that three of these insulins (Con-Ins G1, Con-Ins T1A and Con-Ins K1) are capable of lowering blood glucose in a mouse model of T1D demonstrating their in vivo activity in a mammalian model system of the disease. Here, INS is linked to type 1 diabetes mellitus.